|Date||Thursday, July 1st , 2021|
|Time||10:00 pm - 11:30 pm|
There’s no doubt that Covid has utterly transformed the pharmaceutical industry – from staff working remotely, changed engagement with HCPs and patients moving from physical to digital consultations and now slowly moving back into a working model – which has utterly changed.
While the past year and a half has been extremely challenging, it has demonstrated a need to evolve the previous model of engagement. Research has shown that future engagement strategies will not simply be a case of digital v face-to-face. Instead there needs to be a holistic blending of approaches – multi-channel or omni-channel engagement. This round table discussion aims to bring pharma leaders together to discuss a number of topics and answer questions from the attendees.
Audrey Derveloy, General Manager – Novartis
Born and brought up in France, married, Audrey is a mother of two children. A physician by training, she was inspired by learning in Paris with internationally renowned health professionals. A family’s project has led her to work also in Asia, where she has been living for 3 years in Hong Kong. She joined the pharmaceutical industry in an American laboratory in medical affairs successively in different therapeutic areas. In 2013, she joined Novartis in particular for the richness of its portfolio and its big focus in very innovative medicines. She was at the head of the medical department in Ophthalmology. In 2017, she was given the commercial management of the marketing and sales of this unit. Extremely innovative sector in retina diseases such as wet Age Macular Degeneration and more recently with the 1st gene therapy approved in Europe for a rare hereditary retinal dystrophy. In January 2020 she was appointed General manager of Novartis Pharma and Country president and was delighted to move with her family to Dublin.
Eimear Caslin, General Manager – GSK
As General Manager of GSK’s Pharma business in Ireland, Eimear is accountable for aligning a high performance team, focused on delivering results using GSK’s values of transparency, respect, integrity and patient focus. She prides herself on her team’s ability to identify and navigate complex or ambiguous situations by developing effective solutions which ultimately deliver on GSK’s purpose to help patients do more, feel better and live longer.
Eimear has worked in GSK for over 27 years and has led several transformational programmes across operational, cultural and digital dimensions. She took up the position of General Manager in 2017 and is particularly passionate about culture, development and enabling individuals to be the best version of themselves.
Deirdre Kelly, Country Manager – Consilient Health operations in Ireland, GCC and Malta
Deirdre joined Consilient Health in 2014 and is responsible for the Consilient Health commercial operations and medicine distribution partnerships in Ireland, GCC and Malta. Prior to joining Consilient Health, Deirdre worked in both Ireland and the UK for both medium and large sized pharmaceutical companies. Deirdre has a background in science, marketing and business and represents Consilient Health as a member of the Medicines For Ireland trade association.
Deirdre strongly believes in the power of collaborative partnerships and enjoys working with various partners to bring clinically relevant medicines to patients. She lives in Dublin with her husband Chris and daughter Elizabeth and loves reading, some exercise! and catching up with her family.
Shane Ryan, General Manager – Takeda Ireland
Shane has been General Manager of Takeda for a number of years and was part of their start up team in 2010 in Ireland. He has more than 22 years industry experience having worked for a number of companies in a variety of roles from customer facing roles through to strategic management. He holds a BA Hons in Chemistry from Trinity College, a diploma in Marketing, Advertising & Public Relations from Griffith College and a Diploma in Pharmaceutical Business Management from UCD Michael Smurfit Graduate Business School.
Shane is Deputy Vice President of IPHA where he chairs the IPHA Code, Communications/Advocacy and Governance groups and is a member of the IPHA-state agreement negotiating team. He has a particular interest in equitable access to medicines, industry reputation and societal impact. Outside work, he has a busy family life and enjoys spending time with his wife and four children, as well as being a sports enthusiast, competitor and kids’ coach.
Sharon Rice, Commercial Manager – United Drug Distributors Ireland Limited – A McKesson Company
Sharon holds a BSc from University College Dublin and an MSc in Pharmaceutical Chemistry and Pharmacology in Trinity College. She has held a number of different positions within the pharmaceutical sector including Medical Rep, Product Manager, Sales Manager & National Sales Manager for a number of international branded companies. As Commercial Manager for Irelands largest pharmaceutical pre-wholesaler Sharon’s role involves the creation and management of partnerships with manufacturers, HCP’s and key contacts within the HSE and government agencies.
One of her key strengths is the ability to assess opportunities for improvement and engagement and the implementation of complex solutions across multiple stakeholders.
The Voice of Pharma series is proudly supported by: